Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Isolyser/Microtek

This article was originally published in The Gray Sheet

Executive Summary

Isolyser/Microtek: Revise previously announced merger agreement due to the "recent trading prices of Isolyser common stock below $13 per share which, under the previous merger agreement, would have netted Microtek's shareholders substantially less than" the agreed on price of $16.50 per share, the companies say. Isolyser, developer of the Orex Degradables technology, and Microtek, a manufacturer of disposable drapes and fluid control pouches, announced plans to merge in March ("The Gray Sheet" March 25, I&W-9). Under revised terms of the deal, Microtek shareholders will receive $16.50 of Isolyser stock if the average price of Isolyser shares is between $10 and $15 per share. Microtek shareholders will receive one share of Isolyser stock for each Microtek share if Isolyser stock trades above $15; they will receive 1.65 shares of Isolyser stock if Isolyser trades for $10 or below. Both firms retain an option to terminate the deal if Isolyser shares dip below $10...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006271

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel